1 Market Overview

• 1.1 Product Overview and Scope of Neurologic Disorders Therapeutics
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Neurologic Disorders Therapeutics by Type
  • 1.3.1 Overview: Global Neurologic Disorders Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
  • 1.3.2 Global Neurologic Disorders Therapeutics Consumption Value Market Share by Type in 2023
  • 1.3.3 Central Nervous System (CNS)
  • 1.3.4 Peripheral Nervous System (PNS)
• 1.4 Global Neurologic Disorders Therapeutics Market by Application
  • 1.4.1 Overview: Global Neurologic Disorders Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
  • 1.4.2 Paralysis
  • 1.4.3 Muscle Weakness
  • 1.4.4 Poor Coordination
  • 1.4.5 Loss of Sensation
  • 1.4.6 Seizures
  • 1.4.7 Confusion
  • 1.4.8 Pain and Altered Levels of Consciousness
• 1.5 Global Neurologic Disorders Therapeutics Market Size & Forecast
• 1.6 Global Neurologic Disorders Therapeutics Market Size and Forecast by Region
  • 1.6.1 Global Neurologic Disorders Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
  • 1.6.2 Global Neurologic Disorders Therapeutics Market Size by Region, (2019-2030)
  • 1.6.3 North America Neurologic Disorders Therapeutics Market Size and Prospect (2019-2030)
  • 1.6.4 Europe Neurologic Disorders Therapeutics Market Size and Prospect (2019-2030)
  • 1.6.5 Asia-Pacific Neurologic Disorders Therapeutics Market Size and Prospect (2019-2030)
  • 1.6.6 South America Neurologic Disorders Therapeutics Market Size and Prospect (2019-2030)
  • 1.6.7 Middle East and Africa Neurologic Disorders Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

• 2.1 Biogen Inc.
  • 2.1.1 Biogen Inc. Details
  • 2.1.2 Biogen Inc. Major Business
  • 2.1.3 Biogen Inc. Neurologic Disorders Therapeutics Product and Solutions
  • 2.1.4 Biogen Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 2.1.5 Biogen Inc. Recent Developments and Future Plans
• 2.2 F. Hoffmann-La Roche Ltd.
  • 2.2.1 F. Hoffmann-La Roche Ltd. Details
  • 2.2.2 F. Hoffmann-La Roche Ltd. Major Business
  • 2.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product and Solutions
  • 2.2.4 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 2.2.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
• 2.3 Johnson & Johnson Services Inc.
  • 2.3.1 Johnson & Johnson Services Inc. Details
  • 2.3.2 Johnson & Johnson Services Inc. Major Business
  • 2.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product and Solutions
  • 2.3.4 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 2.3.5 Johnson & Johnson Services Inc. Recent Developments and Future Plans
• 2.4 Novartis AG
  • 2.4.1 Novartis AG Details
  • 2.4.2 Novartis AG Major Business
  • 2.4.3 Novartis AG Neurologic Disorders Therapeutics Product and Solutions
  • 2.4.4 Novartis AG Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 2.4.5 Novartis AG Recent Developments and Future Plans
• 2.5 Pfizer Inc.
  • 2.5.1 Pfizer Inc. Details
  • 2.5.2 Pfizer Inc. Major Business
  • 2.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Product and Solutions
  • 2.5.4 Pfizer Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 2.5.5 Pfizer Inc. Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Neurologic Disorders Therapeutics Revenue and Share by Players (2019-2024)
• 3.2 Market Share Analysis (2023)
  • 3.2.1 Market Share of Neurologic Disorders Therapeutics by Company Revenue
  • 3.2.2 Top 3 Neurologic Disorders Therapeutics Players Market Share in 2023
  • 3.2.3 Top 6 Neurologic Disorders Therapeutics Players Market Share in 2023
• 3.3 Neurologic Disorders Therapeutics Market: Overall Company Footprint Analysis
  • 3.3.1 Neurologic Disorders Therapeutics Market: Region Footprint
  • 3.3.2 Neurologic Disorders Therapeutics Market: Company Product Type Footprint
  • 3.3.3 Neurologic Disorders Therapeutics Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Neurologic Disorders Therapeutics Consumption Value and Market Share by Type (2019-2024)
• 4.2 Global Neurologic Disorders Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

• 5.1 Global Neurologic Disorders Therapeutics Consumption Value Market Share by Application (2019-2024)
• 5.2 Global Neurologic Disorders Therapeutics Market Forecast by Application (2025-2030)

6 North America

• 6.1 North America Neurologic Disorders Therapeutics Consumption Value by Type (2019-2030)
• 6.2 North America Neurologic Disorders Therapeutics Consumption Value by Application (2019-2030)
• 6.3 North America Neurologic Disorders Therapeutics Market Size by Country
  • 6.3.1 North America Neurologic Disorders Therapeutics Consumption Value by Country (2019-2030)
  • 6.3.2 United States Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 6.3.3 Canada Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 6.3.4 Mexico Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)

7 Europe

• 7.1 Europe Neurologic Disorders Therapeutics Consumption Value by Type (2019-2030)
• 7.2 Europe Neurologic Disorders Therapeutics Consumption Value by Application (2019-2030)
• 7.3 Europe Neurologic Disorders Therapeutics Market Size by Country
  • 7.3.1 Europe Neurologic Disorders Therapeutics Consumption Value by Country (2019-2030)
  • 7.3.2 Germany Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 7.3.3 France Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 7.3.4 United Kingdom Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 7.3.5 Russia Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 7.3.6 Italy Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

• 8.1 Asia-Pacific Neurologic Disorders Therapeutics Consumption Value by Type (2019-2030)
• 8.2 Asia-Pacific Neurologic Disorders Therapeutics Consumption Value by Application (2019-2030)
• 8.3 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region
  • 8.3.1 Asia-Pacific Neurologic Disorders Therapeutics Consumption Value by Region (2019-2030)
  • 8.3.2 China Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 8.3.3 Japan Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 8.3.4 South Korea Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 8.3.5 India Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 8.3.6 Southeast Asia Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 8.3.7 Australia Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)

9 South America

• 9.1 South America Neurologic Disorders Therapeutics Consumption Value by Type (2019-2030)
• 9.2 South America Neurologic Disorders Therapeutics Consumption Value by Application (2019-2030)
• 9.3 South America Neurologic Disorders Therapeutics Market Size by Country
  • 9.3.1 South America Neurologic Disorders Therapeutics Consumption Value by Country (2019-2030)
  • 9.3.2 Brazil Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 9.3.3 Argentina Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

• 10.1 Middle East & Africa Neurologic Disorders Therapeutics Consumption Value by Type (2019-2030)
• 10.2 Middle East & Africa Neurologic Disorders Therapeutics Consumption Value by Application (2019-2030)
• 10.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country
  • 10.3.1 Middle East & Africa Neurologic Disorders Therapeutics Consumption Value by Country (2019-2030)
  • 10.3.2 Turkey Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 10.3.3 Saudi Arabia Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)
  • 10.3.4 UAE Neurologic Disorders Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

• 11.1 Neurologic Disorders Therapeutics Market Drivers
• 11.2 Neurologic Disorders Therapeutics Market Restraints
• 11.3 Neurologic Disorders Therapeutics Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Neurologic Disorders Therapeutics Industry Chain
• 12.2 Neurologic Disorders Therapeutics Upstream Analysis
• 12.3 Neurologic Disorders Therapeutics Midstream Analysis
• 12.4 Neurologic Disorders Therapeutics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Neurologic Disorders Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Neurologic Disorders Therapeutics industry chain, the market status of Paralysis (Central Nervous System (CNS), Peripheral Nervous System (PNS)), Muscle Weakness (Central Nervous System (CNS), Peripheral Nervous System (PNS)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neurologic Disorders Therapeutics.
Regionally, the report analyzes the Neurologic Disorders Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neurologic Disorders Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neurologic Disorders Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neurologic Disorders Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Central Nervous System (CNS), Peripheral Nervous System (PNS)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neurologic Disorders Therapeutics market.
Regional Analysis: The report involves examining the Neurologic Disorders Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neurologic Disorders Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neurologic Disorders Therapeutics:
Company Analysis: Report covers individual Neurologic Disorders Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neurologic Disorders Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Paralysis, Muscle Weakness).
Technology Analysis: Report covers specific technologies relevant to Neurologic Disorders Therapeutics. It assesses the current state, advancements, and potential future developments in Neurologic Disorders Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neurologic Disorders Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neurologic Disorders Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Central Nervous System (CNS)
Peripheral Nervous System (PNS)
Market segment by Application
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness
Market segment by players, this report covers
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neurologic Disorders Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurologic Disorders Therapeutics, with revenue, gross margin and global market share of Neurologic Disorders Therapeutics from 2019 to 2024.
Chapter 3, the Neurologic Disorders Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neurologic Disorders Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurologic Disorders Therapeutics.
Chapter 13, to describe Neurologic Disorders Therapeutics research findings and conclusion.